Comprehensive study demonstrates that a new anti-mycotoxin agent alleviates aflatoxin B1 toxicity in Nile tilapia, indicating its potential as a feed additive.
Aflatoxin B1 (AFB1) contamination of aquaculture feed poses serious health risks to fish and consumers. In this study, the efficacy of a novel anti‐mycotoxin agent specific for aquatic species (AM‐AQ) containing bentonite, sepiolite, and orange peel meal ( Citrus Sinensis ) in alleviating AFB1 toxicity in Nile tilapia ( Oreochromis niloticus ) was evaluated. Fish were fed a basal diet as a control group and diets containing AFB1 (50 μg/kg), AM‐AQ (3 g/kg), or a combination of both for 6 weeks. AFB1 exposure significantly reduced growth, altered hematological parameters, protein profile, and digestive enzyme activities ( p < 0.05), and suppressed respiratory burst activity ( p < 0.001). It also altered the expression of liver and kidney function enzymes, lysozyme, and pro‐inflammatory cytokines and generated oxidative stress ( p < 0.05, p < 0.01). AM‐AQ supplementation effectively counteracted these adverse effects by restoring these parameters to control levels. Notably, AM‐AQ reduced AFB1 residues in the musculature by 99.6% after 6 weeks ( p < 0.001). Histopathological analysis revealed severe liver, spleen, and intestinal damage in the group exposed to AFB1, which was markedly ameliorated by AM‐AQ treatment ( p < 0.05). These results demonstrate that the AM‐AQ is a promising feed additive for protecting Nile tilapia against AFB1 toxicity and for reducing AFB1 transfer to edible tissues. Further research is required to optimize its application in aquaculture.
No takes yet. Share an insight, caveat, or question.
Zahran et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: